Expression profiling of a genetic animal model of depression reveals novel molecular pathways underlying depressive-like behaviours

PLoS ONE

Volumn 5, Issue 9, 2010, Pages 1-10

  Blaveri, Ekaterini ^f   Kelly, Fiona ^a   Mallei, Alessandra ^b   Harris, Kriss ^a   Taylor, Adam ^a   Reid, Juliet ^a   Razzoli, Maria ^c   Carboni, Lucia ^c   Piubelli, Chiara ^c   Musazzi, Laura ^b   Racagni, Girogio ^b,c,d,e   Mathé, Aleksander ^d   Popoli, Maurizio ^b   Domenici, Enrico ^c   Bates, Stewart ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

^b UNIVERSITY OF MILAN   (Italy)

^c GSK   (Italy)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^e Instituto di Ricovero e Cura a Carattere Scientifico   (Italy)

^f IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR BETA2; 4 AMINOBUTYRIC ACID A RECEPTOR BETA3; BETA ACTIN; BUNGAROTOXIN RECEPTOR; CARBONATE DEHYDRATASE III; CHOLINERGIC RECEPTOR; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; INTERLEUKIN ENHANCER BINDING FACTOR 3; MEMBRANE PROTEIN; MUSCARINIC M2 RECEPTOR; RIBONUCLEASE; SEROTONIN 1A RECEPTOR; SEROTONIN 2A RECEPTOR;

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEPRESSION; FRONTAL CORTEX; GENE EXPRESSION PROFILING; GENETIC MODEL; HIPPOCAMPUS; MALE; MEDICAL RESEARCH; MICROARRAY ANALYSIS; MOLECULAR MECHANICS; NEUROCHEMISTRY; NONHUMAN; PREFRONTAL CORTEX; RAT; REAL TIME POLYMERASE CHAIN REACTION; ANIMAL; DISEASE MODEL; GENETICS; HUMAN; METABOLISM; PSYCHOLOGICAL ASPECT;

ANIMALIA; RATTUS;

ANIMALS; BEHAVIOR, ANIMAL; DEPRESSION; DISEASE MODELS, ANIMAL; GENE EXPRESSION PROFILING; HUMANS; MALE; RATS;

EID: 77958521878     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0012596     Document Type: Article

References (57)

1. Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, et al. (2005) Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 62: 593-602.
2. Nestler EJ, Gould E, Manji H, Buncan M, Duman RS, et al. (2002) Preclinical models: status of basic research in depression. Biol Psychiatry 52: 503-528.
3. Overstreet DH (1993) The Flinders sensitive line rats: a genetic animal model of depression. Neurosci Biobehav Rev 17: 51-68.
4. Overstreet DH, Friedman E, Mathe AA, Yadid G (2005) The Flinders Sensitive Line rat: a selectively bred putative animal model of depression. Neurosci Biobehav Rev 29: 739-759.
5. Overstreet DH (2002) Behavioral characteristics of rat lines selected for differential hypothermic responses to cholinergic or serotonergic agonists. Behav Genet 32: 335-348.
6. Overstreet DH, Pucilowski O, Rezvani AH, Janowsky DS (1995) Administration of antidepressants, diazepam and psychomotor stimulants further confirms the utility of Flinders Sensitive Line rats as an animal model of depression. Psychopharmacology (Berl) 121: 27-37.
7. Zangen A, Overstreet DH, Yadid G (1997) High serotonin and 5-hydroxyindoleacetic acid levels in limbic brain regions in a rat model of depression: normalization by chronic antidepressant treatment. J Neurochem 69: 2477-2483.
8. Aston C, Jiang L, Sokolov BP (2005) Transcriptional profiling reveals evidence for signaling and oligodendroglial abnormalities in the temporal cortex from patients with major depressive disorder. Mol Psychiatry 10: 309-322.
9. Choudary PV, Molnar M, Evans SJ, Tomita H, Li JZ, et al. (2005) Altered cortical glutamatergic and GABAergic signal transmission with glial involvement in depression. Proc Natl Acad Sci U S A 102: 15653-15658.
10. Klempan TA, Sequeira A, Canetti L, Lalovic A, Ernst C, et al. (2009) Altered expression of genes involved in ATP biosynthesis and GABAergic neurotransmission in the ventral prefrontal cortex of suicides with and without major depression. Mol Psychiatry 14: 175-189.
11. Sequeira A, Gwadry FG, Ffrench-Mullen JM, Canetti L, Gingras Y, et al. (2006) Implication of SSAT by gene expression and genetic variation in suicide and major depression. Arch Gen Psychiatry 63: 35-48.
12. Tochigi M, Iwamoto K, Bundo M, Sasaki T, Kato N, et al. (2008) Gene expression profiling of major depression and suicide in the prefrontal cortex of postmortem brains. Neurosci Res 60: 184-191.
13. Kohen R, Kirov S, Navaja GP, Happe HK, Hamblin MW, et al. (2005) Gene expression profiling in the hippocampus of learned helpless and nonhelpless rats. Pharmacogenomics J 5: 278-291.
14. Kroes RA, Panksepp J, Burgdorf J, Otto NJ, Moskal JR (2006) Modeling depression: social dominance-submission gene expression patterns in rat neocortex. Neuroscience 137: 37-49.
15. Nakatani N, Aburatani H, Nishimura K, Semba J, Yoshikawa T (2004) Comprehensive expression analysis of a rat depression model. Pharmacogenomics J 4: 114-126.
16. Orsetti M, Di Brisco F, Canonico PL, Genazzani AA, Ghi P (2008) Gene regulation in the frontal cortex of rats exposed to the chronic mild stress paradigm, an animal model of human depression. Eur J Neurosci 27: 2156-2164.
17. Pearson KA, Stephen A, Beck SG, Valentino RJ (2006) Identifying genes in monoamine nuclei that may determine stress vulnerability and depressive behavior in Wistar-Kyoto rats. Neuropsychopharmacology 31: 2449-2461.
18. Gass P, Leonardi-Essmann F, Zueger M, Spanagel R, Gebicke-Haerter PJ (2008) Transcriptional changes in insulin- and lipid metabolism-related genes in the hippocampus of olfactory bulbectomized mice. J Neurosci. Res 86: 3184-3193.
19. Takahashi K, Saitoh A, Yamada M, Maruyama Y, Hirose N, et al. (2008) Gene expression profiling reveals complex changes in the olfactory bulbectomy model of depression after chronic treatment with antidepressants. J Pharmacol Sci 108: 320-334.
20. Urigüen L, Arteta D, Díez-Alarcia R, Ferrer-Alcón M, Díaz A, et al. (2008) Gene expression patterns in brain cortex of three different animal models of depression. Genes Brain Behav 7: 649-658.
21. Abel EL (1993) Physiological correlates of the forced swim test in rats. Physiol Behav 54: 309-317.
22. Cullinan WE, Herman JP, Battaglia DF, Akil H, Watson SJ, et al. (1995) Pattern and time course of immediate early gene expression in rat brain following acute stress. Neuroscience 64: 477-505.
23. Overstreet DH, Russell RW (1982) Selective breeding for diisopropyl fluorophosphate-sensitivity: behavioural effects of cholinergic agonists and antagonists. Psychopharmacology (Berl) 78: 150-155.
24. Janowsky DS, Overstreet DH, Nurnberger JI Jr. (1994) Is cholinergic sensitivity a genetic marker for the affective disorders? Am J Med Genet 54: 335-344.
25. Overstreet DH (1986) Selective breeding for increased cholinergic function: development of a new animal model of depression. Biol Psychiatry 21: 49-58.
26. Jiménez-Vasquez PA, Diaz-Cabiale Z, Caberlotto L, Bellido I, Overstreet D, et al. (2007) Electroconvulsive stimuli selectively affect behavior and neuropeptide Y (NPY) and NPY Y(1) receptor gene expressions in hippocampus and hypothalamus of Flinders Sensitive Line rat model of depression. Eur Neuropsychopharmacol 17: 298-308.
27. Mathé AA, Husum H, El Khoury A, Jiménez-Vasquez P, Gruber SH, et al. (2007) Search for biological correlates of depression and mechanisms of action of antidepressant treatment modalities. Do neuropeptides play a role? Physiol Behav 92: 226-231.
28. Serova L, Sabban EL, Zangen A, Overstreet DH, Yadid G (1998) Altered gene expression for catecholamine biosynthetic enzymes and stress response in rat genetic model of depression. Brain Res Mol Brain Res 63: 133-138.
29. Janowsky DS, el Yousef MK, Davis JM, Sekerke HJ (1972) A cholinergicadrenergic hypothesis of mania and depression. Lancet 2: 632-635.
30. Comings DE, Wu S, Rostamkhani M, McGue M, Iacono WG, et al. (2002) Association of the muscarinic cholinergic 2 receptor (CHRM2) gene with major depression in women. Am J Med Genet 114: 527-529.
31. Osterlund MK, Overstreet DH, Hurd YL (1999) The flinders sensitive line rats, a genetic model of depression, show abnormal serotonin receptor mRNA expression in the brain that is reversed by 17beta-estradiol. Brain Res Mol Brain Res 74: 158-166.
32. Nishi K, Kanemaru K, Diksic M (2009) A genetic rat model of depression, Flinders sesnitiveline, has a lower density of 5HT(1A) receptors, but a higher density of 5HT(1B) receptors, compared to control rats. Neurochem Int 54: 299-307.
33. Wallis E, Overstreet DH, Crocker AD (1998) Selective breeding for increased cholinergic function: increased serotonergic sensitivity. Pharmacol Biochem Behav 31: 345-350.
34. Arango V, Underwood MD, Gubbi AV, Mann JJ (1995) Localized alterations in pre- and postsynaptic serotonin binding sites in the ventrolateral prefrontal cortex of suicide victims. Brain Res 688: 121-133.
35. Khait VD, Huang YY, Zalsman G, Oquendo MA, Brent DA, et al. (2005) Association of serotonin 5-HT2A receptor binding and the T102C polymorphism in depressed and healthy Caucasian subjects. Neuropsychopharmacology 30: 166-172.
36. Lesch KP, Beckmann H (1990) The serotonin hypothesis of depression. Fortschr Neurol Psychiatr 58: 427-438.
37. Mann JJ, Stanley M, McBride PA, McEwen BS (1986) Increased serotonin2 and beta-adrenergic receptor binding in the frontal cortices of suicide victims. Arch Gen Psychiatry 43: 954-959.
38. Mann JJ (2003) Neurobiology of suicidal behaviour. Nat Rev Neurosci 4: 819-828.
39. Pandey GN, Dwivedi Y, Rizavi HS, Ren X, Pandey SC, et al. (2002) Higher expression of serotonin 5-HT(2A) receptors in the postmortem brains of teenage suicide victims. Am J Psychiatry 159: 419-429.
40. Lemonde S, Turecki G, Bakish D, Du L, Hrdina PD, et al. (2003) Impaired repression at a 5-hydroxytryptamine 1A receptor gene polymorphism associated with major depression and suicide. J Neurosci 23: 8788-8799.
41. Petty F (1994) Plasma concentrations of gamma-aminobutyric acid (GABA) and mood disorders: a blood test for manic depressive disease? Clin Chem 40: 296-302.
42. Roy A, DeJong J, Ferraro T (1991) CSF GABA in depressed patients and normal controls. Psychol Med 21: 613-618.
43. Sanacora G, Mason GF, Rothman DL, Behar KL, Hyder F, et al. (1999) Reduced cortical gamma-aminobutyric acid levels in depressed patients determined by proton magnetic resonance spectroscopy. Arch Gen Psychiatry 56: 1043-1047.
44. Cohen-Cole S, Kitchin W (1985) Adrenoleukodystrophy and psychiatric disorder. Am J Psychiatry 142: 1224-1225.
45. Molzer B, Stockler S, Bernheimer H (1992) Peroxisomal neurologic diseases and Refsum disease: very long chain fatty acids and phytanic acid as diagnostic markers. Wien Klin Wochenschr 104: 665-670.
46. Wehr H, Zaremba J (1991) Function and diseases of peroxisomes. Neurol Neurochir Pol 25: 769-774.
47. Ng F, Berk M, Dean O, Bush AI (2008) Oxidative stress in psychiatric disorders: evidence base and therapeutic implications. Int J Neuropsychopharmacol 11: 851-876.
48. Baskys A, Bayazitov I, Zhu E, Fang L, Wang R (2007) Rab-mediated endocytosis: linking neurodegeneration, neuroprotection, and synaptic plasticity? Ann N Y Acad Sci 1122: 313-329.
49. Thakker-Varia S, Alder J, Crozier RA, Plummer MR, Black IB (2001) Rab3A is required for brain-derived neurotrophic factor-induced synaptic plasticity: transcriptional analysis at the population and single-cell levels. J Neurosci 21: 6782-6790.
50. Sakane A, Manabe S, Ishizaki H, Tanaka-Okamoto M, Kiyokage E, et al. (2006) Rab3 GTPase-activating protein regulates synaptic transmission and plasticity through the inactivation of Rab3. Proc Natl Acad Sci U S A 103: 10029-10034.
51. Andriamampandry C, Muller C, Schmidt-Mutter C, Gobaille S, Spedding M, et al. (2002) Mss4 gene is up-regulated in rat brain after chronic treatment with antidepressant and down-regulated when rats are anhedonic. Mol Pharmacol 62: 1332-1338.
52. Chow TW, Pollock BG, Milgram NW (2007) Potential cognitive enhancing and disease modification effects of SSRIs for Alzheimer's disease. Neuropsychiatr Dis Treat 3: 627-636.
53. Porsolt RD, Bertin A, Jalfre M (1977) Behavioral despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn Ther 229: 327-336.
54. Barbon A, Popoli M, La Via L, Moraschi S, Vallini I, et al. (2006) Regulation of editing and expression of glutamate alpha-amino-propionic-acid (AMPA)/kainate receptors by antidepressant drugs. Biol Psychiatry 59: 713-720.
55. Glowinski J, Iversen LL (1966) Regional studies of catecholamines in the rat brain. I. The disposition of [3H]norepinephrine, [3H]dopamine and [3H]dopa in various regions of the brain. J Neurochem 13: 655-669.
56. Weng L, Dai H, Zhan Y, He Y, Stepaniants SB, et al. (2006) Rosetta error model for gene expression analysis. Bioinformatics 22: 1111-1121.
57. Bond BC, Virley DJ, Cairns NJ, Hunter AJ, Moore GB, et al. (2002) The quantification of gene expression in an animal model of brain ischaemia using TaqMan real-time RT-PCR. Brain Res Mol Brain Res 106: 101-116.